On Sector Alpha's independent 0–100 composite (qualitative + quantitative, not a buy/sell call), Apollo Hospitals Enterprise Ltd ranks #1 at 74/100. Rainbow Childrens Medicare Ltd (73) and Global Health Ltd (70) follow. Aster DM Healthcare Ltd, Krishna Institute of Medical Sciences Ltd, Healthcare Global Enterprises Ltd — the largest, most-celebrated names — rank mid-pack: strong businesses trading late in their valuation cycle.
The ranking blends six factors — growth, margins, cash, cycle & valuation, management and growth-lever durability. Sector backdrop: Synchronized bed-supply expansion manufacturing tomorrow's high-ROCE assets. The cheapest stock is not automatically the best — full 15-name ranking, factor scores and source-backed evidence are below.
sector_qualitative_bundles + cross_sector_chains + sector_capital_flowsEach lever is mapped to a principle in our mental-model graph and backed by the stock's own evidence — tap a lever to see the proof.
mental_models · evidence from stock_timelines / stock_insights / concallstock_timelines + management_dossiers + catalyst_dcf_overlays + pipeline_decisions + filingsAn independent composite across six factors — not a buy/sell call. Each name is scored 0–100, then blended by fixed weights. Tap a row for the factor detail.
Based on publicly available financial data and company disclosures. Educational research, not investment advice.
On Sector Alpha's independent 0–100 composite, Apollo Hospitals Enterprise Ltd ranks first at 74/100. "Best" means best-scored across growth, margins, cash, valuation, management and growth-lever durability — it is a relative research ranking, not a buy recommendation. The quant factors update live from the latest data; the qualitative factors are refreshed on each curated run.
Names like Aster DM Healthcare Ltd, Krishna Institute of Medical Sciences Ltd, Healthcare Global Enterprises Ltd are excellent businesses but tend to sit late in their valuation cycle — most of the re-rating is behind them and the multiple leaves little margin of safety. The ranking rewards where the cycle, cash and earnings still have room, not size.
(1) Synchronized bed-supply expansion manufacturing tomorrow's high-ROCE assets; (2) Two proven operating models, both working; (3) ARPOB/ARPP inflation via high-acuity case-mix shift, not just price; (4) Rising insurance penetration + inelastic demographic demand.
(1) Regulatory price-cap risk is now realized, not theoretical; (2) Peak multiples on temporarily J-curve-depressed earnings — the #1 false positive; (3) Government-payer AR drag + cash-conversion stress; (4) Synchronized capex + construction-cost inflation + clinician scarcity.
By headline multiple, Indraprastha Medical Corporation Ltd (≈19.4× earnings) and Kovai Medical Center & Hospital Ltd (≈27.2× earnings) screen cheapest. But cheap is not the same as best — cheapness can signal a value trap, which is why the ranking weighs cash quality and management alongside valuation.
Each stock is scored 0–100 on six factors — growth, margins, cash, cycle & valuation, management and growth-lever durability — blending live quantitative data (12-quarter fundamentals, 5-year price/PE/EPS curves, DCF cross-check) with qualitative evidence (source-backed why-notes from concalls, management dossiers and filings). The quant factors recompute from the latest data; the qualitative factors hold until the next curated refresh. It is a relative research ranking, not a buy/sell rating.
These FAQs are based on publicly available market data, company disclosures and financial metrics. This is educational research for studying sector and stock fundamentals — it is not investment advice. Sector Alpha is not SEBI registered and does not provide buy/sell recommendations. Scores are relative and update as new data arrives.
Hospitals deep dive · live quant from the database + curated qualitative · updated 2026-06-21